IP Verse

Spatially Distinguished, Multiplex Nucleic Acid Analysis Of Biological Specimens - EP3901281

The patent EP3901281 was granted to Illumina on Jul 30, 2025. The application was originally filed on Apr 4, 2016 under application number EP21164281A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3901281

ILLUMINA
Application Number
EP21164281A
Filing Date
Apr 4, 2016
Status
Patent Maintained As Amended
Jun 27, 2025
Grant Date
Jul 30, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLEAug 23, 2023ADMISSIBLE

Patent Citations (90) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2002055100
DESCRIPTIONUS2002150909
DESCRIPTIONUS2003205632
DESCRIPTIONUS2004002090
DESCRIPTIONUS2004096853
DESCRIPTIONUS2005037393
DESCRIPTIONUS2005064460
DESCRIPTIONUS2005130173
DESCRIPTIONUS2005179746
DESCRIPTIONUS2005191698
DESCRIPTIONUS2006039823
DESCRIPTIONUS2006164490
DESCRIPTIONUS2006194331
DESCRIPTIONUS2007023292
DESCRIPTIONUS2007099208
DESCRIPTIONUS2007128624
DESCRIPTIONUS2008009420
DESCRIPTIONUS2008108082
DESCRIPTIONUS2008124252
DESCRIPTIONUS2009026082
DESCRIPTIONUS2009127589
DESCRIPTIONUS2009192044
DESCRIPTIONUS2009283407
DESCRIPTIONUS2009321262
DESCRIPTIONUS2010096266
DESCRIPTIONUS2010111768
DESCRIPTIONUS2010120098
DESCRIPTIONUS2010137143
DESCRIPTIONUS2010282617
DESCRIPTIONUS2011048951
DESCRIPTIONUS2011059865
DESCRIPTIONUS2014066318
DESCRIPTIONUS2014079923
DESCRIPTIONUS2014243224
DESCRIPTIONUS2014342921
DESCRIPTIONUS2015005447
DESCRIPTIONUS5130238
DESCRIPTIONUS5455166
DESCRIPTIONUS5599675
DESCRIPTIONUS5641658
DESCRIPTIONUS5750341
DESCRIPTIONUS6210891
DESCRIPTIONUS6214587
DESCRIPTIONUS6258568
DESCRIPTIONUS6266459
DESCRIPTIONUS6274320
DESCRIPTIONUS6355431
DESCRIPTIONUS6565727
DESCRIPTIONUS6770441
DESCRIPTIONUS6773566
DESCRIPTIONUS6859570
DESCRIPTIONUS6911132
DESCRIPTIONUS6977033
DESCRIPTIONUS7052244
DESCRIPTIONUS7057026
DESCRIPTIONUS7115400
DESCRIPTIONUS7163612
DESCRIPTIONUS7211414
DESCRIPTIONUS7244559
DESCRIPTIONUS7315019
DESCRIPTIONUS7328979
DESCRIPTIONUS7329492
DESCRIPTIONUS7405281
DESCRIPTIONUS7547380
DESCRIPTIONUS7595883
DESCRIPTIONUS7641779
DESCRIPTIONUS7960120
DESCRIPTIONUS8288103
DESCRIPTIONUS8460865
DESCRIPTIONUS8486625
DESCRIPTIONUS8637242
DESCRIPTIONUS8778849
DESCRIPTIONUS8895249
DESCRIPTIONUS8951781
DESCRIPTIONWO0063437
DESCRIPTIONWO2004018497
DESCRIPTIONWO2005010145
DESCRIPTIONWO2007120241
DESCRIPTIONWO2007123744
DESCRIPTIONWO2008093098
DESCRIPTIONWO2012058096
DESCRIPTIONWO2014142841
DESCRIPTIONWO8910977
DESCRIPTIONWO9106678
OPPOSITIONWO2013150083
OPPOSITIONWO2014060483
OPPOSITIONWO2015031691
OPPOSITIONWO2016138496
SEARCHWO2013150083
SEARCHWO2014060483

Non-Patent Literature (NPL) Citations (23) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BAINS et al., Journal of Theoretical Biology, (19880000), vol. 135, no. 3, pages 303 - 7-
DESCRIPTION- BENTLEY et al., Nature, (20080000), vol. 456, pages 53 - 59-
DESCRIPTION- DEAN et al., Proc Natl. Acad. Sci. USA, (20020000), vol. 99, pages 5261 - 66-
DESCRIPTION- DRESSMAN et al., Proc. Natl. Acad. Sci. USA, (20030000), vol. 100, pages 8817 - 8822-
DESCRIPTION- DRMANAC et al., Nature Biotechnology, (19980000), vol. 16, pages 54 - 58-
DESCRIPTION- FODOR et al., Science, (19950000), vol. 251, no. 4995, pages 767 - 773-
DESCRIPTION- GUNDERSON et al., Genome Research, (20040000), vol. 14, pages 870 - 877-
DESCRIPTION- KORLACH et al., Proc. Natl. Acad. Sci. USA, (20080000), vol. 105, pages 1176 - 1181-
DESCRIPTION- LAGE et al., Genome Research, (20030000), vol. 13, pages 294 - 307-
DESCRIPTION- LEVENE et al., Science, (20030000), vol. 299, pages 682 - 686-
DESCRIPTION- LIZARDI et al., Nat. Genet., (19980000), vol. 19, pages 225 - 232-
DESCRIPTION- LUNDQUIST et al., Opt. Lett., (20080000), vol. 33, pages 1026 - 1028-
DESCRIPTION- RONAGHI et al., Analytical Biochemistry, (19960000), vol. 242, no. 1, pages 84 - 9-
DESCRIPTION- RONAGHI et al., Science, (19980000), vol. 281, no. 5375, page 363-
DESCRIPTION- RONAGHI, Genome Res, (20010000), vol. 11, no. 1, pages 3 - 11-
DESCRIPTION- SHENDURE et al., Science, (20050000), vol. 309, pages 1728 - 1732-
DESCRIPTION- THORNTON, Ann. Rev. Mater. Sci., (19770000), vol. 7, pages 239 - 60-
DESCRIPTION- WALKER et al., Nucl. Acids Res, (19920000), vol. 20, pages 1691 - 96-
DESCRIPTION- DHINDSA et al., "Virtual Electrowetting Channels: Electronic Liquid Transport with Continuous Channel Functionality", Lab Chip, (20100000), vol. 10, doi:10.1039/b925278a, pages 832 - 836, XP007912321
OPPOSITION- Anonymous, "2022 Sequencing Market Share - Same As It Ever Was (For Now)", 2022 Sequencing Market Share, SanDiegOmics, (20230625), pages 1 - 7, 2022 Sequencing Market Share, URL: https://sandiegomics.com/2022-sequencing-market-share-same-as-it-ever-was-for-now/, XP093155894-
OPPOSITION- Anonymous, "Frequently Asked Questions", TUFTS - TUCF Genomics : Frequently Asked Questions, TUFTS - TUCF Genomics, (20150326), pages 1 - 4, TUFTS - TUCF Genomics : Frequently Asked Questions, URL: https://web.archive.org/web/20150326035029/http://tucf-genomics.tufts.edu:80/home/faq, XP093155900-
OPPOSITION- Bernadette Toner, "In Sequence Survey: Illumina Holds Two-Thirds of Sequencing Market, Splits Desktop Share with Ion PGM", GenomeWeb: Diagnostics - Clinical Sequencing, GenomeWeb, (20121003), pages 1 - 6, GenomeWeb: Diagnostics - Clinical Sequencing, URL: https://www.genomeweb.com/clinical-sequencing/sequence-survey-illumina-holds-two-thirds-sequencing-market-splits-desktop-share, XP093155889-
OPPOSITION- Illumina, "ILLUMINA ® SEQUENCING Multiplexed Sequencing with the Illumina Genome Analyzer System", (20080101), URL: https://www.illumina.com/Documents/products/datasheets/datasheet_sequencing_multiplex.pdf, (20211006), XP055848108-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents